Cite
HARVARD Citation
Centore, M. et al. (n.d.). Intravenous antiplatelet therapy with cangrelor vs. tirofiban in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. European heart journal. p. . [Online].